Amicus Therapeutics, Inc. ( FOLD ) was a big mover last session, as the company saw its shares surge nearly 20% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 62.20% in the past one-month time frame.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, yesterday's price action is encouraging, so make sure to keep a close watch on this firm in the near future]
Amicus Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other attractive players in the healthcare industry include ANI Pharmaceuticals, Inc. ( ANIP ), Actelion Ltd. ( ALIOF ) and Biogen Idec Inc. ( BIIB ), all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AMICUS THERAPT (FOLD): Free Stock Analysis Report
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
ACTELION LTD (ALIOF): Get Free Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research